D – Day: starting D1 at admittance to the hospital, three days after onset of diarrhea; PICU – Pediatric intensive care unit; W – treatment at the hospital ward, P-CRP – C-reactive protein (mg/L; ref <3 mg/L); B-WBC – white blood count (x109/L); B-Hemoglobin (g/L; ref 100-150 g/L) ; B-Hematocrit (%; 37-41 %); P-Na (Sodium) (mmol/L; ref 137-145 mmol/L); P-K (potassium)( mmol/L ; ref 3.7-4.6 mmol/L; S-LDH- lactate dehydrogenase (µkat/L; ref 2.2 – 5.3 µkat/L) ; P-Creatinine (µmol/L; ref 17-42 µmol/L) ; P-Urea (mmol/l; ref 3.1 – 7.8 mmol/L), SAG - packed red cells diluted with saline-adenine-glucose-mannitol solution, (P – plasma, B - blood, S - serum). |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
D – Day: starting D1 at admittance to the hospital, three days after onset of diarrhea; PICU – Pediatric intensive care unit; W – treatment at the hospital ward, P-CRP – C-reactive protein (mg/L; ref <3 mg/L); B-WBC – white blood count (x109/L); B-Hemoglobin (g/L; ref 100-150 g/L) ; B-Hematocrit (%; 37-41 %); P-Na (Sodium) (mmol/L; ref 137-145 mmol/L); P-K (potassium)( mmol/L ; ref 3.7-4.6 mmol/L; S-LDH- lactate dehydrogenase (µkat/L; ref 2.2 – 5.3 µkat/L) ; P-Creatinine (µmol/L; ref 17-42 µmol/L) ; P-Urea (mmol/l; ref 3.1 – 7.8 mmol/L), SAG - packed red cells diluted with saline-adenine-glucose-mannitol solution, (P – plasma, B - blood, S - serum). |
Antibiotic treatment for infection with Shiga toxin producing Escherichia coli infection inducing a hemolytic uremic syndrome
Table 1.
Course of events and laboratory variables.